Search All News
A study of more than 500 hospitalized COVID patients found that comorbidities do not necessarily result in the worst outcomes.
Six scientists at Columbia have received NIH “High-Risk” grants that support exceptionally creative scientists and unconventional approaches to solving major challenges in medicine.
The grant to the Vagelos College of Physicians and Surgeons will help medical researchers speed the application of scientific discoveries, so that new treatments can be delivered to patients faster.
Wang received the prize, awarded annually to immigrants whose work demonstrates exceptional insight or innovation, for his development of synthetic biology tools.
- September 9, 2021
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.
- September 9, 2021
The risk of late-term stillbirth is three times higher for women who use both tobacco and alcohol during pregnancy, a new study has found.
- September 3, 2021
New proposed test values for iron deficiency could double the number of women and triple the number of children detected with the condition.
- August 30, 2021
Researchers at Columbia University Vagelos College of Physicians and Surgeons are leading the first U.S. trial of an experimental vaccine designed to treat an opioid use disorder.
- August 16, 2021
A new preclinical study provides the first direct evidence that loss of a placental hormone during pregnancy alters long-term brain development, causing autism-like behaviors in male offspring.
- August 4, 2021
Keith Diaz, May Hua, Jennifer Woo Baidal, and Hanrui Zhang will receive funding over the next three years to support their clinical and translational research.
- August 3, 2021
A fat ‘shield’ that protects natural killer cells from self-destruction also allows some cancer cells to evade destruction by the immune system, researchers at Columbia University have found.
- August 2, 2021
A new podcast explores explores breakthrough innovations being developed in Columbia’s scientific laboratories.